HRES 803 119th Congress

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Latest Action

Referred to the House Committee on Energy and Commerce.

Congress.gov

Sponsors

Actions

2025-10-10T00:00:00

Referred to the House Committee on Energy and Commerce.

2025-10-10T00:00:00

Submitted in House

2025-10-10T00:00:00

Submitted in House

Policy Areas

Health

Track this bill on CivicBeacon

Get push notifications when this bill is updated, contact your reps, and take action.

Download on the App Store Get it on Google Play